Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts. [PDF]
Vaughn BA +15 more
europepmc +1 more source
Nuclear medicine imaging to guide antibiotic therapy: an expert review. [PDF]
Albano D, Lauri C, Signore A, Treglia G.
europepmc +1 more source
Linker Chemistry in Radiopharmaceutical Design. [PDF]
Stoddard A +5 more
europepmc +1 more source
Head-to-head comparison of [<sup>177</sup>Lu]Lu-FAP-2286 and [<sup>161</sup>Tb]Tb-FAP-2286 efficacy in a PDAC mouse model. [PDF]
van der Heide CD +9 more
europepmc +1 more source
Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer. [PDF]
Sinha A +5 more
europepmc +1 more source
Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. [PDF]
Luhung A, Hasanah AN, Ramdhani D.
europepmc +1 more source
Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling Updates. [PDF]
Koo H +8 more
europepmc +1 more source
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]
Fricke JG +14 more
europepmc +1 more source
A comparative assessment of radiochemical purity and yield of [<sup>18</sup>F]PSMA-1007 production using two different automated synthesis platforms: a head-to-head comparison. [PDF]
Cossandi M +11 more
europepmc +1 more source
Correction: Assessing the potential of bacterial signal peptides for radiopharmaceutical applications. [PDF]
Al Taleb Z +5 more
europepmc +1 more source

